fbpx Skip to main content

Member's Profile

Cend Therapeutics Inc.

12544 High Bluff Dr Ste 400
San Diego,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2018
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Cend Therapeutics Inc.
Biotech Company
Cend Therapeutics Inc. is a La Jolla -based biopharmaceutical company dedicated to developing next generation cancer therapies designed to overcome the barriers of drug delivery to solid tumors. The clinical-stage lead asset, CEND-1, activates a drug transport mechanism by means of tumor-selective molecular mimicry, leading to an enhanced uptake and deep solid tumor penetration of various types of co-administered anti-cancer agents. The proprietary technology has been studied and validated in more than 140 studies / publications, and is currently being studied in a multi-site trial in pancreatic cancer patients. Several other solid tumors trials are under preparation.
Related News
No related news posted by this Member